Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins

Maryna Perepelyuk, Christina Maher, Ashakumary Lakshmikuttyamma, Sunday A Shoyele Department of Pharmaceutical Science, College of Pharmacy, Thomas Jefferson University, Philadelphia, PA, USA Abstract: MicroRNAs (miRNAs) are potentially attractive candidates for cancer therapy. However, their ther...

Full description

Saved in:
Bibliographic Details
Main Authors: Perepelyuk M, Maher C, Lakshmikuttyamma A, Shoyele SA
Format: article
Language:EN
Published: Dove Medical Press 2016
Subjects:
Online Access:https://doaj.org/article/2e56db46bd7c4fd595fce7573e714264
Tags: Add Tag
No Tags, Be the first to tag this record!